【ホリエモン最新】この話を聞いてゾッとしました…テレビで報道されない新型コロナワクチンが「がん」に効く可能性がある研究について【堀江貴文/コロナウイルス/医療/健康/ニュース】

A study at an American university found that when patients receiving immune checkpoint inhibitors for brain cancer and melanoma were given the COVID-19 messenger RNA vaccine, survival rates dramatically increased. As explained in the original paper, the increase appears to be significant. The mechanism by which this occurs is not yet fully understood, but hypotheses have been put forward. The mechanism by which immune checkpoint inhibitors work is based on three types of proteins that allow immune cells, or lymphatic cells, to attack what they perceive as foreign substances. It appears that eye cells block this . It sends a signal that says “no attack ” and slows down the attack, inhibiting immune checkpoints . Blocking specific proteins, such as Opsy , is one of several checkpoint inhibitors. They are highly effective against certain types of cancer, particularly those cells that secrete proteins that weaken the immune system and trick T cells into not attacking the body . There have even been reported cases where they completely disappear. They’re so effective, they’re called immune checkpoint inhibitors. They target a very important part of the immune system, and because they inhibit this function , many people experience side effects. They can only be used in certain people, but they’re not particularly well-known for cancer or melanoma , which is a skin condition that isn’t very common in Japanese people. They’re very effective against these, so when this patient was given the messenger gene vaccine, their condition dramatically improved. It appears that the immune system may be activated . It’s not particularly good at this, but the vaccine was developed for infectious diseases like COVID-19, and it breaks down into two parts. First, the receptor cells deliver messenger RNA to the cells, which are surrounded by lipid nanoparticles (LNPs), or lipid nanoparticles (LNPs). The cells are then transported to the receptor cells, which then deliver the messenger RNA to the receptor cells. When these lipid nanoparticles attach to the receptor cells, the immune system is activated, producing inflammatory cytokines and allowing the receptor cells to mature. The receptor cells then present the signaling molecules derived from the messenger RNA to the lymphocytes, which then recognize and activate the signal, launching an attack. In the case of COVID-19, this is called the spike protein, which is the part the virus attaches to. There’s a part that attaches to cells , and if you block that, it attacks them, or rather, it targets them, but it’s divided into two stages. This activates the immune system, creating a photon source and significantly improving the photon targeting function. At that time, it’s said to be involuntary, but since the infectious virus’s spike protein, not just the original photon, is being presented, the photon targeting function of the virus is also strengthened, and as a result, T cells are said to be more aggressive in attacking cells. At least, there’s a lot of data to suggest this . There are papers out there that say this is true in Japanese research, and it’s very promising. On the other hand , people in the anti-Turboganga community who were saying it would actually worsen cancer are crying. Originally, messenger vaccines were designed to attack cells, but due to the COVID-19 outbreak, a vaccine for that was developed first. However, since the vaccine was originally designed to target eye cells, I think it will continue to evolve. So, I think that’s all for today’s news commentary. Have a nice day. [Music] [Applause] [Music]

ご視聴ありがとうございます。

0:00 新型コロナワクチンががんに効く？正直いいます

【チャンネル登録はこちら】
https://www.youtube.com/@ホリエモンのヤバい話

【堀江貴文ホリエモン Youtubeチャンネル】
https://www.youtube.com/user/takaponjp

【元動画】
コロナワクチンが「がん」に効く可能性があるという研究について解説します